Loading...
CVRX logo

CVRx, Inc.NasdaqGS:CVRX Stock Report

Market Cap US$257.6m
Share Price
US$9.83
n/a
1Y-35.8%
7D-0.2%
Portfolio Value
​
View

CVRx, Inc.

NasdaqGS:CVRX Stock Report

Market Cap: US$257.6m

CVRx (CVRX) Stock Overview

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. More details

CVRX fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Revenue is forecast to grow 17.01% per year

Risk Analysis

Currently unprofitable and not forecast to become profitable over the next 3 years


CVRX Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

CVRX logo
CVRx

Reimbursement Cuts Will Hinder Prospects Even As Device Uptake Persists

Key Takeaways Reimbursement cuts, economic headwinds, and slow adoption are set to limit revenue growth and keep the company unprofitable for an extended period. Narrow product indications and rising competition from alternative technologies threaten market share and further constrain long-term growth potential.
View narrative
US$7
FV
40.4% overvalued intrinsic discount
13.88%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
CVRX logo
CVRx

Aging Population And Chronic Diseases Will Boost Heart Therapy Adoption

Key Takeaways Accelerated account expansion, effective talent strategies, and disease trends position CVRx for growth exceeding current forecasts and analyst expectations. Advancements in technology, digital integration, and global reach could significantly enhance both revenue quality and longer-term profitability.
View narrative
US$14
FV
29.8% undervalued intrinsic discount
23.09%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CVRX logo
CVRx

CPT Code Change Will Expand Heart Failure Treatment Adoption

Key Takeaways Upcoming reimbursement improvements and expanded clinical evidence are set to boost physician adoption, leading to higher procedure volumes and increased revenue leverage. Strategic sales force expansion and targeted education will drive sustained demand, better market penetration, and enhanced long-term profitability.
View narrative
US$10.83
FV
9.3% undervalued intrinsic discount
21.07%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
View Stock Community

CVRx, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for CVRx
Historical stock prices
Current Share PriceUS$9.83
52 Week HighUS$18.55
52 Week LowUS$4.30
Beta1.25
1 Month Change-9.07%
3 Month Change25.22%
1 Year Change-35.84%
3 Year Change-31.93%
5 Year Changen/a
Change since IPO-64.89%

Recent News & Updates

CVRx, Inc. (NASDAQ:CVRX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.50

Nov 08
CVRx, Inc. (NASDAQ:CVRX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.50

After Leaping 39% CVRx, Inc. (NASDAQ:CVRX) Shares Are Not Flying Under The Radar

Oct 16
After Leaping 39% CVRx, Inc. (NASDAQ:CVRX) Shares Are Not Flying Under The Radar

Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Sep 16
Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Recent updates

CVRx, Inc. (NASDAQ:CVRX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.50

Nov 08
CVRx, Inc. (NASDAQ:CVRX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.50

After Leaping 39% CVRx, Inc. (NASDAQ:CVRX) Shares Are Not Flying Under The Radar

Oct 16
After Leaping 39% CVRx, Inc. (NASDAQ:CVRX) Shares Are Not Flying Under The Radar

Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Sep 16
Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Second-Quarter Report

Aug 08
Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Second-Quarter Report

CVRx, Inc.'s (NASDAQ:CVRX) P/S Is Still On The Mark Following 25% Share Price Bounce

Jul 15
CVRx, Inc.'s (NASDAQ:CVRX) P/S Is Still On The Mark Following 25% Share Price Bounce

CVRx: Sell-Off Ignores Its True Potential

Jul 02

Is CVRx (NASDAQ:CVRX) Weighed On By Its Debt Load?

Jun 14
Is CVRx (NASDAQ:CVRX) Weighed On By Its Debt Load?

Investors Appear Satisfied With CVRx, Inc.'s (NASDAQ:CVRX) Prospects As Shares Rocket 25%

May 09
Investors Appear Satisfied With CVRx, Inc.'s (NASDAQ:CVRX) Prospects As Shares Rocket 25%

CVRx, Inc.: Overreaction Creates Buying Opportunity

Apr 09
User avatar

Expanding 48 US Territories And New Codes Will Broaden Access

Expansion in US territories and implanting centers is expected to drive significant revenue growth and market penetration.

With A 29% Price Drop For CVRx, Inc. (NASDAQ:CVRX) You'll Still Get What You Pay For

Mar 07
With A 29% Price Drop For CVRx, Inc. (NASDAQ:CVRX) You'll Still Get What You Pay For

Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 27%

Jan 16
Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 27%

Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Dec 26
Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

CVRx: Impressive Top-Line Growth Seems Priced In

Nov 07

Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Third-Quarter Report

Nov 01
Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Third-Quarter Report

Investors Still Waiting For A Pull Back In CVRx, Inc. (NASDAQ:CVRX)

Oct 10
Investors Still Waiting For A Pull Back In CVRx, Inc. (NASDAQ:CVRX)

Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Jul 31
Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By CVRx, Inc.'s (NASDAQ:CVRX) 32% Share Price Surge

Jun 18
Why Investors Shouldn't Be Surprised By CVRx, Inc.'s (NASDAQ:CVRX) 32% Share Price Surge

The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 47%

May 04
The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 47%

Rock star Growth Puts CVRx (NASDAQ:CVRX) In A Position To Use Debt

Apr 10
Rock star Growth Puts CVRx (NASDAQ:CVRX) In A Position To Use Debt

The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 25%

Feb 29
The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 25%

Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 34%

Nov 11
Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 34%

Shareholder Returns

CVRXUS Medical EquipmentUS Market
7D-0.2%2.5%3.5%
1Y-35.8%3.2%12.0%

Return vs Industry: CVRX underperformed the US Medical Equipment industry which returned 3.5% over the past year.

Return vs Market: CVRX underperformed the US Market which returned 12.5% over the past year.

Price Volatility

Is CVRX's price volatile compared to industry and market?
CVRX volatility
CVRX Average Weekly Movement8.1%
Medical Equipment Industry Average Movement8.7%
Market Average Movement6.5%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market3.0%

Stable Share Price: CVRX has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: CVRX's weekly volatility has decreased from 13% to 8% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000206Kevin Hykeswww.cvrx.com

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors.

CVRx, Inc. Fundamentals Summary

How do CVRx's earnings and revenue compare to its market cap?
CVRX fundamental statistics
Market capUS$257.65m
Earnings (TTM)-US$52.02m
Revenue (TTM)US$55.97m
4.6x
P/S Ratio
-5.0x
P/E Ratio

Is CVRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CVRX income statement (TTM)
RevenueUS$55.97m
Cost of RevenueUS$8.68m
Gross ProfitUS$47.29m
Other ExpensesUS$99.31m
Earnings-US$52.02m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-1.98
Gross Margin84.49%
Net Profit Margin-92.95%
Debt/Equity Ratio102.9%

How did CVRX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/28 11:25
End of Day Share Price 2025/11/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CVRx, Inc. is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William PlovanicCanaccord Genuity
Ross OsbornCantor Fitzgerald & Co.
Chase KnickerbockerCraig-Hallum Capital Group LLC